Valuation : Rayont, Inc.

Market Cap 4.47M 3.85M 3.61M 3.3M 6.21M 427M 6.23M 42.83M 16.71M 216M 16.78M 16.41M 715M P/E 2021
293x
P/E 2022 186x
Enterprise Value 12.25M 10.55M 9.9M 9.03M 17.02M 1.17B 17.07M 117M 45.81M 591M 45.99M 44.99M 1.96B EV / Sales 2021
47.8x
EV / Sales 2022 18.8x
Free-Float
48.18%
Yield 2021 *
-
Yield 2022 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.71% - - 45
-0.69%-1.57%+1.33%+18.35% 50.47B
-6.00%-0.75%+447.48%+524.26% 44.56B
-0.24%+0.74%+37.18%+16.57% 43.08B
-1.55%-2.07%+19.83%+73.63% 41.7B
-0.31%-0.83%+19.47%+48.24% 33.21B
-1.79%-3.24%+26.32%+121.63% 16.77B
-0.58%-2.12% - - 16.28B
+0.08%-1.17%+11.42%+27.38% 14.58B
-1.66%-1.25%+78.49%+39.02% 13.92B
Average -0.90%-1.39%+80.19%+108.63% 30.51B
Weighted average by Cap. -1.03%-1.21%+95.95%+126.43%

Financials

2021 2022
Net sales 2.97M 2.56M 2.4M 2.19M 4.13M 284M 4.14M 28.46M 11.11M 143M 11.15M 10.91M 475M 2.84M 2.45M 2.29M 2.09M 3.94M 271M 3.96M 27.22M 10.62M 137M 10.66M 10.43M 454M
Net income 384K 331K 310K 283K 533K 36.69M 535K 3.68M 1.44M 18.52M 1.44M 1.41M 61.41M 245K 211K 198K 181K 340K 23.4M 341K 2.35M 916K 11.81M 919K 899K 39.17M
Net Debt 2.4M 2.07M 1.94M 1.77M 3.34M 230M 3.35M 23.05M 8.99M 116M 9.03M 8.83M 385M 7.78M 6.7M 6.29M 5.74M 10.81M 744M 10.84M 74.57M 29.1M 375M 29.21M 28.57M 1.24B
Logo Rayont, Inc.
Rayont Inc. operates in the personalized natural healthcare sector in United States and Australia. The Company uses scientific tools, such as deoxyribonucleic acid (DNA), microbiome, iridology and other tests to diagnose and personalize the prescription of natural complementary medicine products, services and treatments to its patients in the markets the Company operate. The Company produces a range of products, including proteins, green blends, sports nutrition, weight management and maintenance, and health and wellness products. The Company's subsidiaries include Rayont (Malaysia) Sdn Bhd, Rayont International (L) Limited, Rayont (Australia) Pty Ltd and Prema Life (USA) Inc.
Employees
-